Sponsored Links


Displaying sitagliptin PowerPoint Presentations

Sitagliptin/Metformin Clinical Slide Kit - Josephine Carlos ... PPT

Presentation Summary : Title: Sitagliptin/Metformin Clinical Slide Kit Author: jim.bergstrom Last modified by: user Created Date: 11/14/2006 11:19:00 PM Document presentation format

Source : http://josephinecarlosraboca.weebly.com/uploads/5/0/2/2/5022425/januvia-janumet_june_24_2010.ppt_final.ppt

Incretin Based Therapy of Type 2 Diabetes Mellitus PPT

Presentation Summary : Incretin Based Therapy of Type 2 Diabetes Mellitus BY Prof ... Dipeptidyl Peptidase-IV Antagonists Sitagliptin and Vildagliptin Sitagliptin and vildagliptin are the ...

Source : http://www.bibalex.org/diabetessupercourse/DiabetesPPTLectures/Copy%20of%20Incretin%20Based%20Therapy%20of%20Type%202%20Diabetes%20Mellitus_1.ppt

American Diabetes Association - DiabetesPro - Home - American ... PPT

Presentation Summary : standards of medical care in diabetes—2012

Source : http://professional.diabetes.org/SlideLibrary/media/4839/ADA%20Standards%20of%20Medical%20Care%202012%20FINAL.ppt

Slide 1 PPT

Presentation Summary : ... JanuMet (Sitagliptin + Metformin) launched in Apr 07. Sales tracking of Januvia franchise > $ 1bn Galvus (Novartis - vildagliptin) launched in Brazil & Mexico.

Source : http://www.glenmarkpharma.com/Common/pdf/Glenmark_Analyst_Ppt.ppt

… View Doc - U S Food and Drug Administration Home Page PPT

Presentation Summary : Sitagliptin Renal Insufficiency Study Design: Open label, single dose Subjects: 24 patients with renal insufficiency (6 mild, 6 moderate, 6 severe ...

Source : http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4351s2-01-GuestSpeakers-corepresentation.ppt

PowerPoint Presentation PPT

Presentation Summary : ... replace SMBG yet! Future Options Inhaled insulin Tritiated compound Mannkind Afresa ® clinical trials DPP 4 inhibitors Sitagliptin, ...

Source : http://www.acponline.org/about_acp/chapters/ak/meet09/desantis2.ppt

PowerPoint Presentation PPT

Presentation Summary : ... (sitagliptin). However, this agent has limited ... Ongoing CV Study at Time of Approval MACE rate control group 12% reduction 15% reduction 18% reduction ...

Source : http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4368s1-06-Guest-Nissen.ppt

Diabetes Case Studies - University of North Dakota PPT

Presentation Summary : Diabetes Case Studies. Eric L. Johnson, M.D. Assistant Professor. Department of Family and Community Medicine. University of North Dakota School of Medicine

Source : http://www.med.und.edu/familymedicine/slidedecks/documents/DiabetesCaseStudiesPA5-25-11.pptx

Differentiating Among Incretin Agents for Type 2 Diabetes ... PPT

Presentation Summary : Differentiating Among Incretin Agents ... Effect on HbA1c and Body Weight Considerations in Choosing a GLP-1 Receptor Agonist EXN Once Weekly vs Sitagliptin ...

Source : http://img.medscape.com/images/779/858/779858_slides.ppt

Core Defects of Type 2 Diabetes - Scioto County Medical ... PPT

Presentation Summary : Core Defects of Type 2 Diabetes Targeting Mechanisms for a Comprehensive Approach * Objectives Discuss challenges in treating type 2 diabetes and rationale for ...

Source : http://sciotocountymedicalsociety.org/documents/MMF4CoreDefectsofType2Diabetes.ppt

Type 2 Diabetes Management Goals - AACE PPT

Presentation Summary : CDC. National diabetes fact sheet, ... Linagliptin, saxagliptin, sitagliptin. Reduce dosage for saxagliptin and sitagliptin ifCrCl <50 mg/dL. Dopamine-2 agonist.

Source : http://outpatient.aace.com/sites/all/files/T2DM-S4-Management-Goals.pptx

Managing Diabetes in Long Term care - Centenary After Hours ... PPT

Presentation Summary : Title: Managing Diabetes in Long Term care Author: Owner Last modified by: Christopher Jyu Created Date: 4/20/2010 2:48:47 PM Document presentation format

Source : http://www.centenaryafterhoursclinic.com/events/DM_Geriatrics_Dr_Zahedi_Nov_10_2012.ppt

053 Slides - Josephine Carlos-Raboca M.D. PPT

Presentation Summary : June 5–9, 2009. Initial Fixed-Dose Combination Therapy With JANUMET™† (sitagliptin/metformin FDC) vs Metformin Monotherapy 079 Study ...

Source : http://josephinecarlosraboca.weebly.com/uploads/5/0/2/2/5022425/pn079_janumet_metformin_ml.ppt

Slide 1 - Scioto County Medical Society PPT

Presentation Summary : Based on the GLP-1 Pathway Terry W. Sherraden, MD, FACE Tallahassee Endocrine Associates ... sitagliptin, and saxagliptin Pharmacologic Agents Exenatide ...

Source : http://sciotocountymedicalsociety.org/documents/Current.Therapy.GLP-1.Sherraden.ppt

INSULIN FOR THE INTERNIST - Saint Agnes Medical Center PPT

Presentation Summary : Using Insulin in the Primary Care Setting: Interactive Cases ... glipizide, and sitagliptin. Decision point 1- WHICH INSULIN/INSULIN REGIMEN DO YOU START?

Source : http://www.samc.com/documents/MedicalEdu/HandoutHIRSCH_InsulinCases2011_1.ppt

Module 01and 02 Epid Diag Criteria 8Mar06 - NVS PPT

Presentation Summary : Baseline Exenatide Sitagliptin Plasma Glucagon (pg/mL) Time (min) Standard Meal -30 0 30 60 90 120 150 180 210 240 70 80 90 100 110 120 Patients with T2D; ...

Source : http://arabicdiabeticforum.com/Abstracts/14.%20Prof.%20Khalifa%20M.%20Abdallah%20Pathophysiology%20of%20Type%202%20Diabetes%20GLP1.ppt

Chronic Disease Management- Diabetes - Welcome — UNC School ... PPT

Presentation Summary : ... (actos) Non-sulfonylurea secretagogues Exanetide (byetta) Sitagliptin (Januvia) Insulin Insulin Summary of Insulin Action Profiles Returns in 3 months

Source : http://www.med.unc.edu/medselect/education/eduactivities/diabetesdayback.ppt

Insulin Management PPT

Presentation Summary : Diabetes Medications Update Eric L. Johnson, M.D. Assistant Medical Director Altru Diabetes Center Altru Health System Associate Professor Department of Community and ...

Source : http://www.diabetesnd.org/image/cache/Diabetes__Medications_Dr._Eric_Johnson_Jan_19_2012.ppt

AC2993 (Synthetic Exendin-4) A Potential New Anti-Diabetic Agent PPT

Presentation Summary : Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure to the ...

Source : http://professional.diabetes.org/UserFiles/Diabetes%20Medication%20Treatment%20in%20the%2021st%20Century.ppt

Control Of Glycemia During Ramadan - The 5th Arab Diabetes ... PPT

Presentation Summary : ... 1237-1242 Incidence of symptomatic hypoglycemia during Ramadan by countries N of Patients ... Diabetics treated with Sitagliptin or a Sulphoylurea during Ramadan.

Source : http://arabicdiabeticforum.com/Abstracts/12.%20Prof.%20Khaled%20Tayeb%20Hypoglycemia%20among%20Type%202%20Diabetics%20Fasting%20Ramadan.ppt

Glycemic Management in Type 2 Diabetes - AACE PPT

Presentation Summary : P <0.001 vs glipizide; † P <0.05 vs sitagliptin. 1. Aschner P, et al. Diabetes Care. 2006;29:2632-2637. 2. Nauck MA, et al. Diabetes Obes Metab

Source : http://outpatient.aace.com/sites/all/files/T2DM-S5-New-Antidiabetic-Therapies-050613.pptx

… Doc Viewer - Oklahoma State University Center for Health ... PPT

Presentation Summary : Sitagliptin Add-on to Glimepiride With or Without Metformin Study: Incidence of Hypoglycemia The addition of sitagliptin 100 mg to ongoing therapy with ...

Source : http://www.healthsciences.okstate.edu/college/clinical/crh/rural_clinic/docs/Joe%20Reese,%20MD.ppt

Antidiabetic Medications - University of Washington PPT

Presentation Summary : ... Inhibitors Sitagliptin (Januvia) 25, 50, 100 mg tablets Sitagliptin/metformin (Janumet) 50/500, 50/1000 mg tablets Saxagliptin (Onglyza) 2.5, ...

Source : http://courses.washington.edu/pharm585/Antidiabetic%20Medications.ppt

Sponsored Links
If you find powerpoint presentation a copyright It is important to understand and respect the copyright rules of the author.
Please do not download if you find presentation copyright.
If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com